BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
(Reuters) — Anthem Inc. could save $3 billion annually on drug costs from a repricing provision in its current contract with pharmacy benefits manager Express Scripts Holding Co., the health insurer's chief executive officer said Tuesday.
Anthem said it is working to renegotiate the contract this year to avoid overpaying for pharmaceuticals based on current market conditions. It first announced that it was going to rework the contract about two years ago, but it has not previously disclosed an estimate on the cost savings from the move.
Anthem's 10-year contract with Express Scripts runs through 2019 but includes the repricing clause that became effective Jan. 1, Joseph Swedish, CEO of the insurer, said in remarks at the J.P. Morgan Healthcare Conference in San Francisco.
"This represents a substantial adjustment to drive lower care costs for our customers and improve our competitive position in the marketplace," Mr. Swedish said.
Express Scripts spokesman Brian Henry said the company is in full compliance with the terms of its agreement with Anthem. The contract calls for negotiations regarding a pricing review, but Anthem is not entitled to $3 billion, Mr. Henry said in an email to Reuters.
Anthem conducted a market analysis to identify the potential savings, which would come primarily from lower generic drug pricing, Swedish said. "We have seen a substantial improvement in market pricing in just the last 12 months," he said.
Mr. Swedish said in an interview with Reuters at the San Francisco conference this week that the company is still undecided about when and if it will sign a new contract with Express Scripts that would go into effect when the current one expires. Negotiations have picked up pace, he said, and he is hopeful about making a decision in 2016 about how to proceed.
Express Scripts values its relationship with Anthem and remains committed to productive discussions regarding its relationship with the insurer, Express Scripts spokesman Mr. Henry said.
Anthem, which manages Blue Cross Blue Shield plans in 14 states, is the country's second-largest health insurer. It could become the nation's largest if its proposal to buy Cigna Corp. is approved by antitrust regulators.
Contract negotiations between Anthem Inc. and Express Scripts Inc. could benefit both companies, especially in light of Anthem's pending acquisition of rival health insurer Cigna Corp.